To further determine the impact of IFN signaling on the resistance of H820 cells to viral infection, we treated these cells with a non-cytotoxic concentration of ruxolitinib (JAK and Tyk2 inhibitor) and infected them with influenza A virus. This evidence concerns the gene TYK2 and viral infectious disease.